Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

HHS Should Track All Rx Clinical Trials, AMA Says

This article was originally published in The Pink Sheet Daily

Executive Summary

All trials should be registered to ensure results are publicly available, physicians’ association says. Institutional review boards should not approve trials unless they are registered, AMA policy urges.

You may also be interested in...



Clinical Trial Sponsors Urged To Post Study Design Details Ahead Of Results

Vermont Assistant Attorney General Brill says disclosure of clinical trial results on a central registry and posting of a study's design and endpoints before the results would suggest "true disclosure," not off-label marketing.

Clinical Trial Sponsors Urged To Post Study Design Details Ahead Of Results

Vermont Assistant Attorney General Brill says disclosure of clinical trial results on a central registry and posting of a study's design and endpoints before the results would suggest "true disclosure," not off-label marketing.

Trial Registries Would Boost Public Trust In Clinical Studies – Survey

Two-thirds of Americans queried in a December 2004 survey believe clinical trials are safe for participants, the Center for Information & Study on Clinical Research Participation reports. More than half of respondents said a public database of clinical trial results would boost their trust in such studies.

Related Content

Topics

UsernamePublicRestriction

Register

PS059682

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel